- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05072431
The Effectiveness of 3D VR Training System for Supporting Volunteers on Adolescents' Illegal Drug Use
September 28, 2021 updated by: National Taiwan Normal University
Examining the Effectiveness of 3D Virtual Reality Training on Problem-solving, Self-efficacy, and Teamwork Among Inexperienced Volunteers Helping With Drug Use Prevention: Randomized Controlled Trial
The purpose of that study was to apply the 3D virtual reality technology to develop a training program aiming at improving the abilities of problem solving, self-efficacy and teamwork of supervisory volunteers on adolescents' illegal drug use.
Study Overview
Detailed Description
Use of illegal drug among adolescents is one of the critical health problems in this age group.
The purpose of that study was to apply the 3D virtual reality technology to develop a training program aiming at improving the abilities of problem solving, self-efficacy and teamwork of supervisory volunteers on adolescents' illegal drug use.
This study used a randomized controlled design with recruiting 68 participants.
The participants in the experimental group received the 3D VR training program and the counterparts in the control group did not receive any intervention.
The participants in the experimental group performed better on problem solving, self-efficacy and teamwork.
In addition, the scores of technology use related variables also supported that experimental participants favored the 3D VR training system.
The findings suggested that the 3D VR training system enhanced the supporting volunteers' abilities to deal with adolescents' illegal drug use.
The 3D VR program showed potential for future promotion to supporting volunteers that contribute to improve volunteers' abilities on dealing with adolescents' illegal drug use.
Study Type
Interventional
Enrollment (Actual)
68
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 106
- National Taiwan Normal University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- accompanies at least an adolescent with drug use to
- having less than 2 year of supporting experiences
- having experiences of using technology products
- able to operate SVVR.
Exclusion Criteria:
- the volunteers who were suffering from cybersickness.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Control group
The control group did not receive any intervention.
|
|
|
EXPERIMENTAL: Experimental group
The participants in the experimental group received the 3D VR training program.
|
The SVVR training program is consisted of five scenarios with tasks.
Before the SVVR training implementation, the research team provided 10-minute orientation session to introduce the purpose of the training.
The 3D VR professional taught the participants how to wear the 3D VR helmets and select the VR scenes, so that the participants could practice multiple times.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The task characteristics
Time Frame: about one month
|
Referenced related literatures (Goodhue, 1995) (Goodhue, 1995), developed 「The task technology characteristics」scale, a total of 3 questions, the task technology characteristics mainly understand the participants' experience in drug use students and related training, the higher scores indicated that participants are experienced in drug use students and related training.
|
about one month
|
|
Problem-solving skills
Time Frame: about one month
|
Referenced relevant literatures (Association of American Colleges & Universities, 2009)(Association of American Colleges & Universities, 2009), developed「Problem-solving skills」scale, a total of 6 questions, The problem-solving skills mainly understand the participants' problem-solving skills in drug use students , the higher scores indicated that participants have better abilities.
|
about one month
|
|
Self-efficacy
Time Frame: about one month
|
Referenced related literatures (Schwarzer, Bäßler, Kwiatek, Schröder, & Zhang, 1997)(Schwarzer, Bäẞler, Kwiatek, Schröder, & Zhang,1997), developed「Self-efficacy」scale, a total of 6 questions, The Self-efficacy mainly understand the participants' confidence in counseling drug use students, the higher scores demonstrated the more confident participants were
|
about one month
|
|
Team cooperation
Time Frame: about one month
|
Referenced relevant literatures (Hughes & Jones, 2011)(Hughes & Jones, 2011), developed「Team cooperation」scale, a total of 4 questions, The Team cooperation mainly understand the participants' Team cooperation abilities in drug use students , the higher scores indicated that participants have better Team cooperation abilities.
|
about one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 1, 2017
Primary Completion (ACTUAL)
October 26, 2018
Study Completion (ACTUAL)
October 31, 2018
Study Registration Dates
First Submitted
September 28, 2021
First Submitted That Met QC Criteria
September 28, 2021
First Posted (ACTUAL)
October 11, 2021
Study Record Updates
Last Update Posted (ACTUAL)
October 11, 2021
Last Update Submitted That Met QC Criteria
September 28, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 201805HS007
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Illicit Drugs
-
University Hospital, MontpellierCompletedMSM | Sexual; Sexual Desire | Illicit DrugsFrance
-
Butler HospitalCompletedIllicit Opioid Drug UseUnited States
-
Assiut UniversityUnknownEpidemiologic Data of Some Synthetic Cannibinoids Toxicity in Patients Presenting at Assiut University Hospital, Psychiatric Hospital of Ministry of Health) | Proportion of Acute and Chronic Abusers of Synthetic Cannibinoids Among Cases of Illicit Drugs Abuser in Studied SitesEgypt
-
Vancouver Infectious Diseases CentreGilead Sciences; Regina General HospitalUnknown
-
NHS Greater Glasgow and ClydePublic Health ScotlandRecruitingDrug Effect | Drug Use | Drug Abuse | Drug Toxicity | Illicit Drug Use | Overdose, Drug | Illicit Drug Overdose | Illicit Drug IntoxicationUnited Kingdom
-
Mohamed ElsayedUniversity of AlexandriaUnknownAnaesthetic Drugs, Hypotensive Drugs, Perioperative AnalgesiaEgypt
-
University Hospital, Clermont-FerrandCSAPA ANPAA 63UnknownOpiate Dependent | Previous Illicit Drug UseFrance
-
Glyn Jones-ElwynDartmouth-Hitchcock Medical Center; Charles H. Hood Foundation; Cayuga County... and other collaboratorsCompletedChildren | Psychotropic Drugs | Shared Decision Making | Patient Decision Aid | Psychiatric DrugsUnited States
-
Jung-min AhnCardioVascular Research Foundation, KoreaCompletedAntiplatelet DrugsKorea, Republic of, India, Turkey
-
Thermo Fisher Scientific OyICON plcCompletedTransplantation Drugs StabilityItaly
Clinical Trials on SVVR training program
-
Education University of Hong KongNot yet recruiting
-
Universidad Pablo de OlavideUniversity of SevilleCompletedObesity | Overweight and Obesity | Overweight or ObesitySpain
-
Cairo UniversityCompletedLow Back PainEgypt
-
Marmara UniversityCompletedHealth Individuals | AtlhetesTurkey
-
Riphah International UniversityCompletedDrug Use and AddictionPakistan
-
University GhentSpecial Research Fund, BelgiumCompletedChronical Rotator Cuff TendinopathyBelgium
-
Philip Morris Products S.A.CompletedSmoking | Exercise CapacityGermany
-
Chang Gung Memorial HospitalCompleted
-
Marmara UniversityCompletedHealth IndividualsTurkey
-
Qassim UniversityCairo UniversityCompletedBurn | Pediatric Burns | Burn RehabilitationEgypt